RecruitingNCT05743049

Collection of Circulating Biomarkers in Pancreatic Cancer

Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer

Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment

30 participants

Start Date

Feb 27, 2023

Study Type

OBSERVATIONAL

Conditions

Pancreas Cancer

Summary

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
The subject must be a patient of the University of Pennsylvania
The subject must be able to provide informed consent
The subject must be 18 years of age or older

Exclusion Criteria1

Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObtaining blood for analysis of various circulating biomarkers

4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Locations(1)

Abramson Cancer Center at University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05743049

Related Trials

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

NCT019152251 location